Showing results (361-370 of 753) with videos related to
Sort By:
Pageof 76
The Prostate|March 13, 2025
Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature ReviewMark Willy L Mondia, Prem P Batchala, Robert Dreicer, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|December 7, 2007
Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastomaYunqing Li, Fadila Guessous, Elizabeth B Johnson, et al.Journal of Neuro-Oncology|September 8, 2010
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomideElizabeth R Gerstner, April F Eichler, Scott R Plotkin, et al.Neurosurgery|May 20, 2011
Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working GroupMichael A Vogelbaum, Sarah Jost, Manish K Aghi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2009
Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q lossMatija Snuderl, April F Eichler, Keith L Ligon, et al.Journal of Neuro-Oncology|June 28, 2011
Safety of concurrent bevacizumab therapy and anticoagulation in glioma patientsAndrew D Norden, Julia Bartolomeo, Shota Tanaka, et al.Archives of Neurology|March 10, 2010
Morphological characteristics of brain tumors causing seizuresJong Woo Lee, Patrick Y Wen, Shelley Hurwitz, et al.Neuro-Oncology|September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.Neuro-Oncology|February 22, 2024
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohortYazmin Odia, Matthew D Hall, Timothy Francis Cloughesy, et al.Neuro-Oncology|November 9, 2019
Biological activity of weekly ONC201 in adult recurrent glioblastoma patientsIsabel Arrillaga-Romany, Yazmin Odia, Varun V Prabhu, et al.Pageof 76